vs
CSG SYSTEMS INTERNATIONAL INC（CSGS）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $323.1M、CSG SYSTEMS INTERNATIONAL INCの約1.5倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 2.2%、差は4.7%）。CSG SYSTEMS INTERNATIONAL INCの前年同期比売上増加率が高い（2.0% vs -1.7%）。過去8四半期でCSG SYSTEMS INTERNATIONAL INCの売上複合成長率が高い（4.6% vs -0.1%）
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
CSGS vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $323.1M | $493.8M |
| 純利益 | $7.0M | $33.7M |
| 粗利率 | 50.0% | — |
| 営業利益率 | 9.0% | 9.9% |
| 純利益率 | 2.2% | 6.8% |
| 売上前年比 | 2.0% | -1.7% |
| 純利益前年比 | -79.7% | 10.5% |
| EPS（希薄化後） | $0.24 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $323.1M | $493.8M | ||
| Q3 25 | $303.6M | $492.9M | ||
| Q2 25 | $297.1M | $468.8M | ||
| Q1 25 | $299.5M | $458.4M | ||
| Q4 24 | $316.7M | $502.4M | ||
| Q3 24 | $295.1M | $511.2M | ||
| Q2 24 | $290.3M | $504.3M | ||
| Q1 24 | $295.1M | $495.1M |
| Q4 25 | $7.0M | $33.7M | ||
| Q3 25 | $20.5M | $71.7M | ||
| Q2 25 | $12.3M | $39.3M | ||
| Q1 25 | $16.1M | $20.7M | ||
| Q4 24 | $34.5M | $30.5M | ||
| Q3 24 | $19.1M | $19.4M | ||
| Q2 24 | $13.8M | $-153.0M | ||
| Q1 24 | $19.5M | $4.0M |
| Q4 25 | 50.0% | — | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 47.3% | — | ||
| Q1 24 | 46.5% | — |
| Q4 25 | 9.0% | 9.9% | ||
| Q3 25 | 10.0% | 13.8% | ||
| Q2 25 | 10.0% | 12.8% | ||
| Q1 25 | 9.8% | 7.0% | ||
| Q4 24 | 13.4% | 7.8% | ||
| Q3 24 | 10.8% | 6.6% | ||
| Q2 24 | 8.8% | -31.3% | ||
| Q1 24 | 10.8% | 3.2% |
| Q4 25 | 2.2% | 6.8% | ||
| Q3 25 | 6.7% | 14.5% | ||
| Q2 25 | 4.1% | 8.4% | ||
| Q1 25 | 5.4% | 4.5% | ||
| Q4 24 | 10.9% | 6.1% | ||
| Q3 24 | 6.5% | 3.8% | ||
| Q2 24 | 4.8% | -30.3% | ||
| Q1 24 | 6.6% | 0.8% |
| Q4 25 | $0.24 | $0.40 | ||
| Q3 25 | $0.73 | $0.84 | ||
| Q2 25 | $0.44 | $0.46 | ||
| Q1 25 | $0.57 | $0.24 | ||
| Q4 24 | $1.20 | $0.37 | ||
| Q3 24 | $0.67 | $0.23 | ||
| Q2 24 | $0.48 | $-1.84 | ||
| Q1 24 | $0.68 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.0M | $375.2M |
| 総負債低いほど良い | $539.5M | $570.5M |
| 株主資本純資産 | $283.7M | $865.9M |
| 総資産 | $1.5B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.90× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.0M | $375.2M | ||
| Q3 25 | $158.4M | $340.1M | ||
| Q2 25 | $145.9M | $224.7M | ||
| Q1 25 | $136.0M | $99.0M | ||
| Q4 24 | $161.8M | $229.9M | ||
| Q3 24 | $118.4M | $103.8M | ||
| Q2 24 | $110.4M | $19.4M | ||
| Q1 24 | $120.8M | $8.0M |
| Q4 25 | $539.5M | $570.5M | ||
| Q3 25 | $538.6M | $577.2M | ||
| Q2 25 | $537.8M | $583.9M | ||
| Q1 25 | $537.6M | $590.5M | ||
| Q4 24 | $538.5M | $597.1M | ||
| Q3 24 | $539.5M | — | ||
| Q2 24 | $540.5M | — | ||
| Q1 24 | $541.5M | — |
| Q4 25 | $283.7M | $865.9M | ||
| Q3 25 | $289.5M | $890.7M | ||
| Q2 25 | $290.7M | $833.8M | ||
| Q1 25 | $283.1M | $789.2M | ||
| Q4 24 | $282.6M | $764.9M | ||
| Q3 24 | $288.4M | $732.5M | ||
| Q2 24 | $273.3M | $706.5M | ||
| Q1 24 | $269.3M | $856.2M |
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.2B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.5B | $2.2B | ||
| Q3 24 | $1.4B | $2.1B | ||
| Q2 24 | $1.4B | $2.0B | ||
| Q1 24 | $1.3B | $2.2B |
| Q4 25 | 1.90× | 0.66× | ||
| Q3 25 | 1.86× | 0.65× | ||
| Q2 25 | 1.85× | 0.70× | ||
| Q1 25 | 1.90× | 0.75× | ||
| Q4 24 | 1.91× | 0.78× | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 2.01× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $59.2M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $55.8M | — |
| FCFマージンFCF / 売上 | 17.3% | — |
| 設備投資強度設備投資 / 売上 | 1.1% | — |
| キャッシュ転換率営業CF / 純利益 | 8.46× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $141.4M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $59.2M | $114.1M | ||
| Q3 25 | $47.9M | $137.3M | ||
| Q2 25 | $37.3M | $137.2M | ||
| Q1 25 | $11.5M | $-117.5M | ||
| Q4 24 | $82.5M | $133.0M | ||
| Q3 24 | $39.5M | $91.8M | ||
| Q2 24 | $43.1M | $107.0M | ||
| Q1 24 | $-29.4M | $-125.2M |
| Q4 25 | $55.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $34.6M | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $76.6M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $38.8M | — | ||
| Q1 24 | $-34.1M | — |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | -11.6% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 8.46× | 3.39× | ||
| Q3 25 | 2.34× | 1.91× | ||
| Q2 25 | 3.04× | 3.49× | ||
| Q1 25 | 0.71× | -5.66× | ||
| Q4 24 | 2.39× | 4.36× | ||
| Q3 24 | 2.07× | 4.72× | ||
| Q2 24 | 3.12× | — | ||
| Q1 24 | -1.51× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
